Business Wire | Aug 10, 2020 08:30AM EDT

Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference

Aug. 10, 2020

BRISBANE, Calif.--(BUSINESS WIRE)--Aug. 10, 2020--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005105/en/

CONTACT: Investor Relations - Global McDavid Stilwell 510-970-6000, x219 mstilwell@sangamo.com Media Inquiries - Global Aron Feingold 510-970-6000, x421 afeingold@sangamo.com